Isis Pharmaceuticals

3 Things to Watch at Isis Pharmaceuticals
Motley Fool
Fri, 12/21/12 - 10:49 am
Isis Pharmaceuticals
Kynamro
When Compared To Isis, Alnylam's Valuation Does Not Make Sense
Seeking Alpha
Wed, 12/19/12 - 01:32 pm
Isis Pharmaceuticals
Alnylam
Isis Pharma, AstraZeneca Ink Deal
Yahoo/Zacks
Sat, 12/15/12 - 12:50 pm
Isis Pharmaceuticals
AstraZeneca
ISIS-STAT3Rx
lymphoma
Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO
Yahoo/Fly on the Wall
Fri, 12/14/12 - 11:47 am
Genzyme
Isis Pharmaceuticals
Kynamro
CHMP
Homozygous Familial Hypercholesterolemia
1 Small Pharma Proving That Partnerships Pay
Motley Fool
Thu, 12/13/12 - 11:04 am
Isis Pharmaceuticals
Biogen Idec
Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders
Yahoo
Mon, 12/10/12 - 10:49 am
Isis Pharmaceuticals
Biogen Idec
antisense
1 Event That Could Make or Break Biotech Stocks
Motley Fool
Thu, 12/6/12 - 10:50 am
Halozyme
Isis Pharmaceuticals
Biomarin
Bristol-Myers Squibb
Sarepta
Isis To Receive $1.25 Million Payment As Pfizer Continues Development Of EXC 001
Yahoo
Fri, 11/2/12 - 10:30 am
Isis Pharmaceuticals
Pfizer
antisense
Excaliard
EXC 001
Isis Means Business With This New Treatment
Wall St. Cheat Sheet
Thu, 11/1/12 - 11:16 am
Isis Pharmaceuticals
ISIS-STAT3
chemotherapy
advanced cancer
cancer
This Week in Biotech
Motley Fool
Sun, 10/21/12 - 10:47 am
Aegerion
Isis Pharmaceuticals
Sanofi
NPS Pharmaceuticals
Aeterna Zentaris
Isis Trading Halts as FDA Reviews Key Drug's Risks
PharmPro
Sat, 10/20/12 - 10:49 am
Isis Pharmaceuticals
Kynamro
hypercholesterolemia
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 10/20/12 - 10:33 am
Isis Pharmaceuticals
Align Technology
MannKind
ISIS Pharma shares rise after FDA panel backs approval for cholesterol drug Kynamro
Yahoo/AP
Fri, 10/19/12 - 11:21 am
Isis Pharmaceuticals
FDA
advisory panels
Kynamro
Isis Pharma/Genzyme FDA Panel Live Blog
TheStreet.com
Thu, 10/18/12 - 11:39 am
Genzyme
FDA
Sanofi
Isis Pharmaceuticals
advisory panels
Aegerion
Homozygous Familial Hypercholesterolemia
mipomersen
Isis Falls on Concerns Over Abnormal Growths With Kynamro
Bloomberg
Tue, 10/16/12 - 11:39 am
Isis Pharmaceuticals
Kynamro
mipomersen
Homozygous Familial Hypercholesterolemia
Aegerion Vs. Isis: Which One Is The Buy?
Seeking Alpha
Mon, 10/15/12 - 10:35 am
Isis Pharmaceuticals
Aegerion
FDA
advisory panels
mipomersen
lomitapide
3 Biotechs Facing the Firing Squad Next Week
Motley Fool
Thu, 10/11/12 - 05:42 pm
Gattex
NPS Pharmaceuticals
lomitapide
Aegerion
Sanofi
Isis Pharmaceuticals
mipomersen
Alnylam-ISIS Venture Prices IPO
Yahoo/Zacks
Sat, 10/6/12 - 11:50 am
Alnylam
Isis Pharmaceuticals
Isis: A Biotechnology Firm Making Its First Step Towards Profitability?
Motley Fool
Tue, 09/18/12 - 04:54 pm
Isis Pharmaceuticals
Isis Pharmaceuticals to receive $1.4 million from Alnylam
Yahoo
Tue, 08/28/12 - 12:25 pm
Isis Pharmaceuticals
Alnylam

Pages